# Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development

> **NCT07033663** · — · RECRUITING · sponsor: **Fundació Sant Joan de Déu** · enrollment: 90 (estimated)

## Conditions studied

- Pregnancy Related
- Immune-mediated Diseases

## Interventions

- **DRUG:** Monoclonal antibody

## Key facts

- **NCT ID:** NCT07033663
- **Lead sponsor:** Fundació Sant Joan de Déu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-01
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-08-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07033663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07033663, "Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07033663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*